A detailed history of Lazard Asset Management LLC transactions in Avita Medical, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 128 shares of RCEL stock, worth $1,602. This represents 0.0% of its overall portfolio holdings.

Number of Shares
128
Holding current value
$1,602
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.72 - $10.87 $988 - $1,391
128 New
128 $1,000
Q1 2024

May 14, 2024

SELL
$12.56 - $18.31 $4,873 - $7,104
-388 Reduced 6.67%
5,428 $87,000
Q4 2023

Feb 14, 2024

BUY
$9.29 - $14.57 $3,771 - $5,915
406 Added 7.5%
5,816 $79,000
Q2 2023

Aug 14, 2023

BUY
$10.7 - $17.48 $28,280 - $46,199
2,643 Added 95.52%
5,410 $92,000
Q1 2023

May 15, 2023

BUY
$6.45 - $14.48 $17,847 - $40,066
2,767 New
2,767 $38,000
Q4 2021

Feb 09, 2022

SELL
$11.72 - $19.66 $43,645 - $73,213
-3,724 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$16.73 - $20.9 $62,302 - $77,831
3,724 New
3,724 $65,000

Others Institutions Holding RCEL

About AVITA Medical, Inc.


  • Ticker RCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,030,900
  • Market Cap $313M
  • Description
  • AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...
More about RCEL
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.